Hip BMD is associated with visceral fat change: a registry study of osteoporosis and sarcopenia.
Ying-Chou ChenYu-Wei WangChi-Hua KoJia-Feng ChenChung-Yuan HsuShan-Fu YuTien-Tsai ChengPublished in: Therapeutic advances in chronic disease (2022)
score was associated with a future decrease in visceral fat, which may decrease the risk of atherosclerosis and CV risk. Therefore, evaluation of visceral fat may be useful for assessing CVD risk in patients with osteoporosis. Effective management of the risk of atherosclerosis and CVD is important in improving the life expectancy of these patients.
Keyphrases
- adipose tissue
- insulin resistance
- end stage renal disease
- postmenopausal women
- cardiovascular disease
- ejection fraction
- bone mineral density
- newly diagnosed
- chronic kidney disease
- fatty acid
- prognostic factors
- peritoneal dialysis
- skeletal muscle
- type diabetes
- metabolic syndrome
- total hip arthroplasty
- patient reported